Dimitra Vini Philippos Servos Marouso Drosou
10.1111/j.1600-0609.2010.01569.x
Eur J Haematol
2011 Mar;86(3):274-5.
CC BY
https://pubmed.ncbi.nlm.nih.gov/21198860/
Benzoates / therapeutic use Iron Chelating Agents / therapeutic use Pregnancy Complications, Hematologic / drug therapy Triazoles / therapeutic use beta-Thalassemia / complications beta-Thalassemia / drug therapy
Benzoates / therapeutic use Iron Chelating Agents / therapeutic use Pregnancy Complications, Hematologic / drug therapy Triazoles / therapeutic use beta-Thalassemia / complications beta-Thalassemia / drug therapy Case Reports Letter Research Support, Non-U.S. Gov't Adult Contraindications Deferasirox Female Humans Infant, Newborn Pregnancy Pregnancy Outcome Benzoates Iron Chelating Agents Triazoles Deferasirox
PMC3123701
21198860
Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
2011